SUCCESSFUL REGISTRATION OF DOMESTIC BIOANALOGUE OF BEVACIZUMAB – NEW OPPORTUNITIES FOR EFFECTIVE TREA TMENT OF PATIENTS WITH NON-SQUAMOUS CELL NON-SMALL CELL LUNG CANCER
Comparison of the efficacy and safety of drugs "Avegra®" and "Avastin®" used in combination with paclitaxel and carboplatin as first-line therapy in patients with locally inoperable or metastatic NSCLC. The study included 138 patients, male and female aged 18 to 75 years with new...
Saved in:
Main Authors: | S. V. Orlov, S. N. Fogt, M. S. Shustova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2016-01-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01) -
Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report
by: Song Xue, et al.
Published: (2025-01-01) -
Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
by: Ke Chen, et al.
Published: (2025-02-01) -
IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01) -
RESULTS OF CLINICAL TRIALS OF MEDICAL TREA TMENT OF RENAL CELL CARCINOMA IN 2014–2015
by: A. M. Popov, et al.
Published: (2016-01-01)